journal article·2024-11Open access

Coating Dormant Collagenase‐Producing Bacteria with Metal‐Anesthetic Networks for Precision Tumor Therapy

Qiuju Han, Fengmin Yang, Mian Chen, Mengmeng Zhang, Lu Wang, Hongxia Wang, Jinyao Liu, Zhenping Cao

Advanced Science· Volume 11· Issue 42

Abstract

Abstract Tumor malignancy highly depends on the stiffness of tumor matrix, which mainly consists of collagen. Despite the destruction of tumor matrix is conducive to tumor therapy, it causes the risk of tumor metastasis. Here, metal‐anesthetic network‐coated dormant collagenase‐producing Clostridium is constructed to simultaneously destruct tumor matrix and inhibit tumor metastasis. By metal‐phenolic complexation and π–π stacking interactions, a Fe3+‐propofol network is formed on bacterial surface. Coated dormant Clostridium can selectively germinate and rapidly proliferate in tumor sites due to the ability of carried Fe3+ ions to promote bacterial multiplication. Intratumoral colonization of Clostridium produces sufficient collagenases to degrade tumor collagen mesh and the loaded propofol restrains tumor metastasis by inhibiting tumor cell migration and invasion. Meanwhile, the delivered Fe3+ ions are reduced to the Fe2+ form by intracellular glutathione, thereby inducing potent Fenton reaction to trigger lipid peroxidation and ultimate ferroptosis of tumor cells. In addition to a satisfactory safety, a single intratumoral injection of coated dormant Clostridium not only effectively retards the growth of established large primary tumors, but also significantly suppresses distal lung metastasis in two different orthotopic tumor models. This work proposes a strategy to develop advanced therapeutics for malignant tumor treatment and metastasis prevention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 200240 China

Department of Medical Oncology Fudan University Shanghai Cancer Center Department of Oncology Shanghai Medical College Fudan University Shanghai 200032 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1007/s00330-013-2866-210.1007/s00330-013-2866-2 ↗
2. 10.1038/s41568-020-00329-710.1038/s41568-020-00329-7 ↗
3. 10.1007/s10585-019-09966-110.1007/s10585-019-09966-1 ↗
4. 10.1038/s41416-021-01680-810.1038/s41416-021-01680-8 ↗
5. 10.1016/j.ccell.2021.02.00710.1016/j.ccell.2021.02.007 ↗
6. 10.1016/j.ccell.2022.06.01110.1016/j.ccell.2022.06.011 ↗
7. 10.1038/nrm390410.1038/nrm3904 ↗
8. 10.1111/bph.1419510.1111/bph.14195 ↗
9. 10.1158/0008-5472.CAN-03-147210.1158/0008-5472.CAN-03-1472 ↗
10. 10.1021/acsnano.9b0239510.1021/acsnano.9b02395 ↗
11. 10.1038/s41467-020-18794-x10.1038/s41467-020-18794-x ↗
12. 10.1080/10717544.2018.147497110.1080/10717544.2018.1474971 ↗
13. 10.1038/s41392-021-00544-010.1038/s41392-021-00544-0 ↗
14. 10.1021/acs.molpharmaceut.8b0031910.1021/acs.molpharmaceut.8b00319 ↗
15. 10.1016/j.jconrel.2023.02.00110.1016/j.jconrel.2023.02.001 ↗
16. 10.1038/s41467-021-26956-810.1038/s41467-021-26956-8 ↗
17. 10.1002/adma.20210666910.1002/adma.202106669 ↗
18. 10.1016/j.addr.2022.11444310.1016/j.addr.2022.114443 ↗
19. 10.1002/advs.20200357210.1002/advs.202003572 ↗
20. 10.1111/1751-7915.1277810.1111/1751-7915.12778 ↗
21. 10.1002/path.199910.1002/path.1999 ↗
22. 10.1016/j.cca.2021.08.01110.1016/j.cca.2021.08.011 ↗
23. 10.1016/j.canlet.2020.03.01810.1016/j.canlet.2020.03.018 ↗
24. 10.1097/MD.000000000001099410.1097/MD.0000000000010994 ↗
25. 10.1126/sciadv.ade099710.1126/sciadv.ade0997 ↗
26. 10.1039/C8NR04312D10.1039/C8NR04312D ↗
27. 10.1038/s41467-019-11390-810.1038/s41467-019-11390-8 ↗
28. 10.1021/jacs.3c0268210.1021/jacs.3c02682 ↗
29. 10.1002/adma.20190700110.1002/adma.201907001 ↗
30. 10.1002/advs.20210400610.1002/advs.202104006 ↗
31. 10.1002/adma.20200737910.1002/adma.202007379 ↗
32. 10.1038/s41467-022-35579-610.1038/s41467-022-35579-6 ↗
33. 10.1038/s41467-019-13727-910.1038/s41467-019-13727-9 ↗
34. 10.1002/adma.20221094910.1002/adma.202210949 ↗
35. Yang F. · bioRxiv · 2024
36. 10.1213/ANE.0b013e318257a38010.1213/ANE.0b013e318257a380 ↗
37. 10.1200/JCO.2021.39.15_suppl.e1509110.1200/JCO.2021.39.15_suppl.e15091 ↗
38. 10.1038/s41401-019-0258-010.1038/s41401-019-0258-0 ↗
39. 10.1038/nrmicro149010.1038/nrmicro1490 ↗
40. 10.1074/jbc.REV120.00774610.1074/jbc.REV120.007746 ↗
41. 10.1080/21691401.2019.162025510.1080/21691401.2019.1620255 ↗
42. 10.1038/nchem.112310.1038/nchem.1123 ↗
43. 10.1021/jacs.1c0747110.1021/jacs.1c07471 ↗
44. 10.1038/s41419-024-06435-w10.1038/s41419-024-06435-w ↗
45. 10.1083/jcb.20180416110.1083/jcb.201804161 ↗
46. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
47. 10.1089/ars.2017.711510.1089/ars.2017.7115 ↗
48. 10.1186/s12943-019-1089-910.1186/s12943-019-1089-9 ↗
49. 10.1126/scitranslmed.300898210.1126/scitranslmed.3008982 ↗
50. 10.1038/s41568-018-0081-910.1038/s41568-018-0081-9 ↗
51. 10.1007/s11033-014-3144-310.1007/s11033-014-3144-3 ↗
52. 10.1038/nprot.2006.43010.1038/nprot.2006.430 ↗
53. 10.1089/ten.tec.2015.028010.1089/ten.tec.2015.0280 ↗